Member Info for bigAl67

Just listened to the investor meet presentation again in order to specifically hear what James Cheek said about the two new sites coming on board !

At 31 minutes into the Presentation James said that we are still pushing for revenue from additional sites as they go live across the UK ''and we had two new sites actually coming on this week'' - So the two new sites actually came on last week ending the 5th April !!

Hi stephen11,

Yes you are right - JC did say in the investormeetcompany presentation that 2 new hospital sites will be coming live this week for the MTRNR-1 !!

Gino Miele

Gino MieleGino Miele

• 2nd• 2nd

CSO, Genedrive. Non-executive director, CytomosCSO, Genedrive. Non-executive director, Cytomos

1w • 1w •

Linkedin

''Absolutely thrilled with this – full recommendation from NICE in their draft guidance for our CYP2C19 test for as the preferred point of care platform of choice in the NHS for genotype guided therapy in ischaemic and transient ischaemic stroke indications. With both of our pharmacogenetic tests receiving recommendations from NICE for use in the UK NHS the future is bright – delighted for us to be part of this emerging paradigm of practical realisation of bedside precision medicine in emergency care. There’s sometimes (understandable) criticism of us with respect to time to market, but below the iceberg tip there’s a phenomenal amount of effort over many years that goes into realising medical devices such as these, especially in previously uncharted territories & developing new markets, even for companies 100X our size. Kudos to the GD team past and present for getting to this point today.''

'Full recommendation' in NICE draft guidance, and in the Presentation Q&A 1:02:20 - Gino stated that their expectation is that NICE will give the Full Recommendation, and they do not anticipate the 'Full Recommendation' will change, though this is a draft guidance at the moment. It is in Public Consultation, and the final recommendation is in early July.

I have always wondered whether the previous Consultation dates moved out in order to gain further information, and NICE to give this Full Recommendation ?!!

Hi tecknik,

Many thanks for your post, always Good to hear your views, much appreciated !!

Hi Jimi,

You are right !!

The following is taken from the RNS 31 Mar 2023 18:32

RNS Number : 0323V

''The Directors have assessed a number of financing options for the Company including an equity raise but believe that the Facility is the best option available to the Company at the present time in order to further fund the Company's progress while also taking consideration of the investor shareholder base. Further, the Directors believe that a combination of the possibility of positive future news flow around the Company's two main assays as well as the potential for reasonable levels of liquidity in the Company's ordinary shares make the Facility the most attractive form of financing for the Company at the current time. ''

The TROLL 'GROUP' are out in Force - LOL

Hi stephen11,

My thoughts are that our Genedrive obviously felt it was important to confirm receipt of the Tax refund in the 1st Qtr of 2024, as expected !! – Hence the RNS.

I hope we hear ‘Good News’ around Special Commissioning; FDA Partnership; FDA Costs; The remaining £1,500,000 RF Funding; UK and other Country updates; etc ?!!

Yep Well done Jimi for exposing the Real Liar/s - I also confirm your wording.

There is a 'Group' of them posting on this BB, and they become even more 'Aggressive and Nasty', as Positive News Increases, and Posters Share their Findings LOL - Many Thanks to All Investors for your research and Postings !!!

Agreed Jimi,

My thoughts too!!

For every Drawdown equal to £300,000, RF have to pay Genedrive £168,000 on Exercise of their received Warrants (Exercise Date unknown).

So far we have Drawndown £1,500,000, with a further £1,500,000 available on agreement of terms.

Should we complete and receive the full total of £3,000,000 in drawdowns, then RF will pay us £1,680,000 on their Exercise of the Total warrants they own !!

As you say Jimi, 'it's very much in their interest to help and support Genedrive when needed''.

It should be noted that the GDR Board have not committed to a fund raise, via a Placing?!

The GDR Board have said they are :- ''planning for an equity or debt raise in early 2024''

We do Not currently have any Debt = Zero Debt,- So a Debt raise 'could possibly' be considered a better option IMVHO !!

Russ Shaw stated that we have £1mil in cash (as of 23rd November), and £300,000 due from RF (Our 3rd Drawdown on 29th November)

Then we had £200k due from DEVOTE Funding

Then we had £600,000 drawdown from RF on the 2nd January

So £1,000,000 + £300,000 drawdown + £600,000 drawdown + £200,000 DEVOTE Funding + £800,000 Tax Refund (due in Qtr 1 2024) = £2,900,000 + Sales revenue?

£2,900,000 at £400,000 per month running costs = 7.25 Months from 23rd November = finance until end of June 2024 !!

Then, should we drawdown the remaining £1,500,000 from RF, we would be looking at finance until approx. November 2024 !!

Then we have otherFunding avenues, under exploration!

And although JC did not expect us to receive the full remaining £1,000,000 funding from DEVOTE, he did expect to receive more funding from DEVOTE !!

Then we have Revenue from Sales up to November 2024 to consider. We have been told that we received our first orders from 6 Countries outside UK (see RNS 20th Dec).

That is correct stephen11 - £300,000 + £600,000 since the 23rd November !!

£300,000 on 29th November, and £600,000 on the 2nd January = £900,000 !!

Expecting a further drawdown from RF soon, and we know we can agree with RF to draw down > £300,000 in any drawdown !!

£800,000 of R&D Tax Refund due soon, if not received already !

£1,500,000 of RF drawdowns outstanding

Total £2,300,000 of income available !

Interestingly the last RF drawdown we received was £600,000, so we know the value of the income from drawdowns is negotiable !

Then we have the prospect of a partner joining in, and/or should e.g. a favourable loan be negotiated !

Last day of Arab Health 2024 today !

@ Slacker,

I reckon you need to recheck your numbers again chap? - the last drawdown was for £600k !!

Hi Livinhope,

Just to clarify my last post - I posted to show that our SP was up (4.65%), at the time I posted, and that it was just a £55 sell that took our SP down into the red.

Volume now 1,842,986

Vol. Sold 358,104

Sold Value £27.98k

Vol. Bought 1,484,882

Market Summary >

Genedrive PLC

7.98 GBX

+0.35 (4.65%)today

Open

7.88

High

8.22

Low

7.38

8 Jan, 11:07 GMT • Disclaimer

A £55 sell took our SP down.

Date Time Trade Prc Volume Buy/Sell Bid Ask Value

08-Jan-24 10:52:49 7.50 740 Sell* 7.50 8.00 55.50 O

08-Jan-24 10:27:49 7.948 100,000 Buy* 7.50 8.00 7,948 O

08-Jan-24 10:21:35 7.948 12,531 Buy* 7.50 8.00 995.96 O

08-Jan-24 10:08:04 7.948 10,000 Buy* 7.50 8.00 794.80 O

08-Jan-24 10:01:42 7.95 33,661 Buy* 7.50 8.00 2,676 O

08-Jan-24 10:00:01 7.95 12,210 Buy* 7.50 8.00 970.70 O

08-Jan-24 09:59:46 7.95 25,107 Buy* 7.50 8.00 1,996

It should be noted that the GDR Board have not committed to a fund raise, via a Placing?!

The GDR Board have said they are :- ''planning for an equity or debt raise in early 2024''

We do Not currently have any Debt = Zero Debt,- so a Debt raise could be considered the Best Option IMVHO !!

Hi Jimi,

I agree that it could well be RF selling off the 650,000 shares today?!

It appears to me that the LSE have not reported/recorded the actual volume today, well not until 14:43 hours?

Hi stephen11,

Yes an £800,000 Tax refund due in Q1 2024 too !!

Hi Nissan,

I believe we will have received a Total of £3,500,000 from the £5,000,000 RF Facility (including todays announcement of a further £600,000)!!

This leaves a possible further £1,500,000 could be drawn down !!

RNS Dates:

31 March 2023

£5 million Equity Prepayment Facility in place with initial draw down of £2 million

02 January 2024

today announces a further scheduled £600,000 draw down

29 November 2023

today announces a further scheduled £300,000 draw down

05 July 2023

today announces a further scheduled £300,000 draw down

02 June 2023

today announces a first £300,000 draw down

Happy New Year stephen11 !!!

Lets not forget our Other gem Product - Our CYP2C19 - Should the NICE Report be Very Favourable, then this could be a Massive Game Changer !!!